Nickolas Papadopoulos

This inventor holds 64 USPTO granted patents and 50 published patent applications, plus 3 CIPO patents and 18 EPO patents, primarily in Cancer Genomics (CPC class C12Q). Top assignees: Johns Hopkins University, Duke University, The State University of New York. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nickolas Papadopoulos. Retrieved from https://idiyas.com/inventor/nickolas-papadopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 64 (Patent Applications = 50)

% Patents Active = 98.4

CIPO Patents = 3 (Patent Applications = 18)

EPO Patents = 18 (Patent Applications = 46)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 510(Granted Patents)

Forward Citations (Not Self Cited) = 386(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Baltimore, MD (US) (1998)
New York, NY (US) (2002)
Brookline, MA (US) (2003 - 2006)
Towson, MD (US) (2014 - 2024)

Company Filing History:

63 out of 3,803

Johns Hopkins University

The State University of New York

patents

4. 1 out of 5,640

The University of Texas System

patents

5. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Cytokine Release Syndrome

Nucleic Acid Assessment

Safe Sequencing

Bottleneck Sequencing

Cancer Assays

Aneuploidy Detection

Tumor-Derived DNA

Checkpoint Blockade

TERT Promoter Mutations

Somatic Mutations

Genetic Alterations

Autoimmune Antigens

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12760375 - DETECTION OF TUMOR-DERIVED DNA IN CEREBROSPINAL FLUID (2026-10-13),

2. 12760101 - COMPOSITIONS AND METHODS FOR IDENTIFYING FUNCTIONAL ANTI-TUMOR T CELL RESPONSES (2026-10-13),

3. 12742205 - SAFE SEQUENCING SYSTEM (2026-09-22),

4. 12674002 - MANAbodies TARGETING TUMOR ANTIGENS AND METHODS OF USING (2026-07-07),

5. 12564622 - PREVENTING CYTOKINE RELEASE SYNDROME (2026-03-03),

6. 12553082 - METHODS AND MATERIALS FOR ASSESSING NUCLEIC ACIDS (2026-02-17),

7. 12534759 - SAFE SEQUENCING SYSTEM (2026-01-27),

8. 12442038 - Methods and materials for assessing nucleic acids (2025-10-14),

9. 12359250 - Bottleneck sequencing (2025-07-15),

10. 12275996 - Head and neck squamous cell carcinoma assays (2025-04-14),

11. 12252743 - Safe sequencing system (2025-03-18),

12. 12209281 - Safe sequencing system (2025-01-28),

13. 12195803 - Methods and materials for assessing and treating cancer (2025-01-14),

14. 12116628 - Rapid aneuploidy detection (2024-10-15),

15. 12054781 - Detection of tumor-derived DNA in cerebrospinal fluid (2024-08-06),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I only provide information within those specific spheres. If you have any requests regarding these topics, feel free to ask!

Profile summary based on public USPTO records.